Generation of de novo specific ligands
It is a technology that allows the de novo generation of artificial protein ligands to identify a target of interest. The use of protein ligands is a stable and simple alternative to the production of monoclonal antibodies that do not present a risk of post-translational modifications. The methodology combines ribosome display, next-generation sequencing, and bioinformatics technologies. The production of ligands in E. coli is reproducible, inexpensive and GMP-compatible.
• Sample sequence if known
Further details on the project may be requested directly by the expert. You will be able to exchange directly with the experts after filling in the form below.
Please answer all questions below to specify your requirements
Please answer all questions. If you are not logged in, you will be redirected.